What is significant about diagnostic or screening tests developed from new biomarkers discovered by Power3 Medical?
For example, Power3 Medical R&D has delivered discovery of specific proteins that signal early stage breast cancer (pre-mammography). These discoveries establish the basis of a very sensitive early breast cancer screening test. We have potentially the first breast cancer diagnostic tool that detects disease before a mass can be detected with existing technology! Just think of the potential impact on millions of women’s lives not to mention the market, PR and branding opportunity! Our company believes that we can deliver a breast cancer mass screening tool to be utilized in the physician’s office or clinic. Future development will direct treatment and monitoring options and drugs so that the disease is contained and ultimately eradicated before the cancer is ever seen on a mammogram. Biomarker discovery and utility proof of concept is complete. Already underway is the platform prototype proof of concept and initiation of prototyping experiments. Power3 Medical anticipates a commercial r
